#news #biotech FDA panel shoots down Lipocine low testosterone drug

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: FDA panel shoots down Lipocine low testosterone drug .A panel of experts convened by the FDA has come down against approval of Lipocine’s testosterone replacement therapy. The panel voted 13-6 against the risk-benefit profile of Tlando, leaving Lipocine looking down the barrel of a rejection with limited cash to mount a fightback.

from FierceBiotech: Biotech http://ift.tt/2DlgiwT